12-chapt13 lecture anim - nassau community · pdf file• vessels merge before entering one...
TRANSCRIPT
8/30/2013
1
1
Chapter 13
Lecture and
Animation Outline
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
See separate PowerPoint slides for all figures and tables pre-inserted into PowerPoint without notes and
animations.
To run the animations you must be in Slideshow View. Use the buttons on the animation to play, pause, and turn
audio/text on or off.
Please Note: Once you have used any of the animation functions (such as Play or Pause), you must first click on the slide’s background before you can advance to the next slide.
2
13.1 The Lymphatic System
• The lymphatic system consists of:
– Lymphatic vessels
– Lymphoid organs
• Three functions contribute to homeostasis.
– Returning excess tissue fluid to the bloodstream
– Absorbing fats from the digestive tract and transporting them to the bloodstream
– Defending the body against disease
3
Lymphatic Vessels
• Lymphatic vessels
– Form a one-way system that begins with lymphatic capillaries
• Lymphatic capillaries
– Found in most areas of the body
– Small, closed-ended vessels with thin walls
– Capillaries merge into larger vessels
• These larger vessels carry the lymph into the thoracic and lymphatic ducts
8/30/2013
2
4
Lymphatic Vessels
• Lymphatic capillaries
– Absorb excess tissue fluid
• Consists of water and solutes
– Nutrients, electrolytes, and oxygen derived from plasma
– Hormones, enzymes, and wastes products secreted by cells
– Return fluid inside, called lymph, to the bloodstream
5
Lymphatic Vessels
• Lymphatic capillaries join to form lymphatic vessels.
• Vessels merge before entering one of two ducts.
– Thoracic duct
• Returns lymph collected from body below thorax, left arm,
left side of head, and neck into the left subclavian vein
– Right lymphatic duct
• Returns lymph from the right arm and right side of the
head and neck into the right subclavian vein
6
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
spleen
tonsil
inguinal lymph nodes
right lymphatic duct
empties lymph into the
right subclavian vein
right subclavian vein
axillary lymph nodes
thoracic duct
left subclavian vein
red bone marrow
thymus
Figure 13.1
8/30/2013
3
7
13.1 Lymphatic System
• Larger lymphatic vessel structure similar to veins– One-way valves prevent lymph backflow
– Movement of lymph dependent on skeletal muscle contractions
• Edema– Localized swelling caused by accumulation of
fluids in the tissues
– Too much fluid made and/or not enough being drained
8
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
tissue cell
lymph node
lymphaticvessel
valve
lymphatic capillary
blood capillary
tissuefluid
lymphaticcapillary
bloodcapillary
Figure 13.1
9
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
spleen
tonsil
inguinal lymph nodes tissue cell
lymph node
right lymphatic duct
empties lymph into the
right subclavian vein
right subclavian vein
axillary lymph nodes
thoracic duct
lymphatic
vessel
valve
lymphatic capillary
blood capillary
tissue
fluid
lymphatic
capillary
blood
capillary
left subclavian vein
red bone marrow
thymus
Figure 13.1
8/30/2013
4
10
Lymphoid Organs
• Lymphoid organs contain many lymphocytes
– White blood cells involved in adaptive immunity
– Two types of lymphoid organs:
• Primary lymphoid organs
• Secondary lymphoid organs
11
Lymphoid Organs
• Primary lymphoid organs
– Where lymphocytes develop and mature
– Red bone marrow, thymus
12
Lymphoid Organs
• Secondary lymphoid organs
– Where lymphocytes become activated
– Spleen, lymph nodes
8/30/2013
5
13
tonsil
lymphaticvessel
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Figure 13.2
14
medulla
tonsil
a. Thymus
641 µm
lobule
cortex
lymphaticvessel
© The McGraw-Hill Companies, Inc./Dennis Strete, photographer
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Figure 13.2a
15
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
medulla monocyte
lymphocyte
tonsil
a. Thymus
641 µm
lobule
cortex
lymphatic
vesselb. Red bone ma rrow
310 µm
a: © The McGraw-Hill Companies, Inc./Dennis Strete, photographer; b: © R. Valentine/Visuals UnlimitedFigure 13.2b
8/30/2013
6
16
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
medulla monocyte
lymphocyte
tonsil
medulla
641 µm
c. Lymph node
capsule
cortex
a. Thymus
641 µm
lobule
cortex
lymphatic
vesselb. Red bone marrow
310 µm
a: © The McGraw-Hill Companies, Inc./Dennis Strete, photographer; b: © R. Valentine/Visuals Unlimited; c: © Fred E. Hossler/Visuals UnlimitedFigure 13.2c
17
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
medulla monocyte
lymphocyte
tonsil
medulla
white pulp
381 µm
d. Spleen
641 µm
c. Lymph node
capsule
cortex
a. Thymus
641 µm
lobule
cortex
lymphatic
vessel
red pulp
capsule
b. Red bone ma rrow
310 µm
a: © The McGraw-Hill Companies, Inc./Dennis Strete, photographer; b: © R. Valentine/Visuals Unlimited; c: © Fred E. Hossler/Visuals Unlimited; d: © The McGraw Hill Companies, Inc./Al Telser, photographer
Figure 13.2d
18
Primary Lymphoid Organs
• Red bone marrow
– Network of connective tissue fibers and stem cells
– Stem cells develop into various white blood cells
– Blood cells enter bloodstream at sinuses
– B cells remain and mature in the bone marrow
– T cells migrate from bone marrow and reach
thymus
8/30/2013
7
19
Primary Lymphoid Organs
• Thymus
– Soft, bilobed organ located between trachea and
the sternum
– Site of T cell maturation
– Site where T cells that are capable of reacting to the body’s own cells undergo apoptosis
• Must distinguish “self” from “non-self”
20
Secondary Lymphatic Organs
• Lymphocytes migrate from the blood into secondary lymphoid organs.
• Lymphocytes may encounter foreign molecules or cells where they proliferate and become
activated.
• Activated lymphocytes reenter the blood, where
they search for sites of infection or inflammation.
21
Secondary Lymphatic Organs
• Spleen is located in the upper left side of
abdominal cavity.
– Mostly red pulp, where macrophages remove old and defective blood cells
– Also contains white pulp, lymphatic tissue where lymphocytes can react to foreign invaders
8/30/2013
8
22
Secondary Lymphatic Organs
• Lymph nodes are small, ovoid structures located along lymphatic vessels, through which
lymph must pass.
• Connective tissue divides organ into nodules and sinuses.
– Each nodule is packed with B and T cells.
– Macrophages engulf pathogens as lymph moves
through.
– Viruses, bacteria and debris in lymph are removed.
23
13.2 Innate Immunity
• The lymphatic system works with the immune system to protect the body from pathogens, toxins
and other invaders.
• Immunity is the body’s ability to remove or kill foreign substances, toxins, pathogens, and cancer cells.
• Innate immunity mechanisms function without
previous exposure to an unwanted substance.
• Adaptive immunity is dependent upon exposure to specific antigens.
24
13.2 Innate Immunity
• Mechanisms of innate immunity are
divided into four types.
– Physical and chemical barriers
– Inflammation
– Phagocytes and natural killer cells
– Protective proteins
8/30/2013
9
25
Physical and Chemical Barriers
• Skin and mucous membranes lining the respiratory, digestive and urinary tracts serve as mechanical
barriers.
• The upper respiratory tract has cilia to remove trapped particles.
• Oil glands on skin secrete chemicals to weaken or kill some bacteria.
• Stomach is acidic.
• Normal bacteria in the intestines and other areas
outcompete potential pathogens.
26
Inflammatory Response
• Inflammation response
– Series of events caused by physical or chemical trauma to tissue or pathogens
– Tends to wall off infections and increase access to
the immune system
– Four signs at inflamed area
• Redness, heat, swelling, and pain
• Caused by changes in the capillaries in damaged area
27
Inflammatory Response
• Three cell types in the skin and connective
tissue promote inflammatory response.
– Mast cells release histamine which causes
capillaries to dilate.
– Macrophages and dendritic cells are
phagocytic and release cytokines.
• Cytokines are chemical messengers that influence
activities of other immune cells.
8/30/2013
10
28
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
mast cell
histamine
cytokines
Skin
Tissue
2. Macrophages and dendritic cellsphagocytize pathogens and release cytokines, which stimulate theinflammatory reaction.
injured tissue
pathogen
macrophage
neutrophil
monocyte
dendriticcell
4. Blood clotting walls offcapillary and preventsblood loss.
3. Neutrophils and monocytes (which becomemacrophages) squeeze through thecapillary wall and phagocytize pathogens.
blood clot
Capillary
1. Injured tissue cells and mast cellsrelease histamine which causes capillaries to dilate and increasesblood flow.
Figure 13.3
29
Phagocytes and Natural Killer Cells
• Phagocytes are cells that migrate through the walls of dilated capillaries.
– Engulf pathogens by forming an endocytic vesicle
– Vesicles fuse with lysosomes (digestive enzymes)
– Neutrophils
• First to arrive at inflamed area, accumulation forms pus
– Monocytes
• As inflammatory response continues monocytes migrate from blood
• When in tissues, these cells become macrophages
30
Phagocytes and Natural Killer Cells
• Natural killer (NK) cells
– Large granular lymphocyte-like cells
– Kill some virus-infected and cancer cells by cell-to-cell contact
– Seek out and kill cells lacking a particular type of
“self” molecule on their surface
• MHC-I (major histocompatibility class I)
• Some cancer or virus-infected cells lack MHC
– Do not recognize specific antigens
8/30/2013
11
31
Protective Proteins
• The complement system consists of plasma proteins designated by the letter C and a
number (i.e C3)
• They complement certain immune actions
– Ex: Certain complement proteins bind to mast cells
and cause histamine release.
– Ex: Certain complement proteins attract phagocytes by binding to pathogen surfaces.
32
Protective Proteins
• Complement System
– “Complement” certain immune responses
– Form membrane attack complexes
• Interferons
– Proteins produced by infected cells that “warn” non-infected cells
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
complement
proteins
membrane
attack complex
fluids
andsalts
Figure 13.4
33
13.3 Adaptive Immunity
• Adaptive Immunity occurs when innate defense fails to prevent an infection.
– System recognizes, responds to and often eliminates antigens
• Antigen: any molecule that stimulates an adaptive immune response
– Immune system is able to distinguish “self” from “nonself”
– Usually takes 5-7 days to become fully activated
• May last for years
8/30/2013
12
34
Antigen Receptor Diversity and Clonal Selection
• Adaptive defenses depend on B and T cells.
– Both cells recognize antigens because they have
specific antigen receptors.
– Each lymphocyte has only one type of receptor.
– Diversity is needed for the many possible antigens.
– Specific B and/or T cells are produced for almost
any possible antigen.
35
Antigen Receptor Diversity and Clonal Selection
• The clonal selection theory states that only a few cells within a population of B and T cells
have antigen receptors for any specific antigen.
• “Selection” occurs when an antigen binds to
receptors of a particular lymphocyte.
– It divides repeatedly, forming clonal cells.
– Only cells that have a receptor specific to an
antigen divide in the process.
36
Antigen Receptor Diversity and Clonal Selection
• Various immune defenses do not ordinarily
react to our own normal cells.
– Our immune system can distinguish “self” from “nonself.”
– However, because generation of antigen
receptors is a random genetic process, some of these receptors can react with “self” antigens.
– Such lymphocytes are destroyed by apoptosis early in development.
8/30/2013
13
37
B Cells and Antibody-Mediated Immunity
• B cells activated in lymph nodes or spleen
when the BCRs bind specific antigens.
• Cytokines secreted from helper T cells
stimulate B cells to divide.
• Defense by B cells is called antibody-
mediated immunity.
– Also called humoral immunity because the
antibodies are found in blood and lymph.
38
B Cells and Antibody-Mediated Immunity
• Activated B cell clones
– Most become plasma cells
• Mass production of antibodies
– Some become memory cells
• Long-term immunity
– If same antigen returns, memory B cells divide and quickly give rise to more plasma cells
39
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
B cell
antigens
B-cell
receptor(BCR)
Figure 13.5
8/30/2013
14
40
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
B cell
antigens
B-cellreceptor(BCR)
Activation cytokines from T cells
Clonal expansion
Memory B cellsFigure 13.5
41
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
B cell
antigens
B-cellreceptor
(BCR)
Activation cytokines from T cells
Figure 13.5
42
B cell Clonal Selection Theory
– An antigen binds to the antigen receptor of only one type of B cell or T cell, and then this B cell or T cell divides, forming clones of itself.
– Only the B cell with a BCR shape that fits the antigen undergoes clonal expansion.
– Most clones become plasma cells, but some become memory cells.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
antibody
Plasma cells
B cell
antigens
B-cell
receptor
(BCR)
Activation cytokines from T cells
Clonal expansion
Memory B cells
Apoptosis
Apoptosis
Figure 13.5
8/30/2013
15
43
B Cells and Antibody-Mediated Immunity
• Structure of an Antibody– Antibodies are also called immunoglobulins (Ig)
– Y-shaped
• Each arm has two chains.
– “Heavy” long chain
– “Light” short chain
• Each chain has two regions.
– Constant (C) regions – constant within same class of
antibody
– Variable (V) regions vary between antibodies
» Binds to antigen
44
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
C C
C = constantV = variable
heavy
chain
light
chain
antigen binds
to binding site
antigen-binding
sites
shape of antigen fits
shape of binding site
antigen
Figure 13.6a
45
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Courtesy Dr. Arthur J. Olson, Scripps Institute
Figure 13.6b
8/30/2013
16
46
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
C C
antigen
a.
C = constant
V = variable
heavychain
lightchain
antigen bindsto binding site
antigen-bindingsites
shape of antigen fitsshape of binding site
b.b: Courtesy Dr. Arthur J. Olson, Scripps Institute
Figure 13.6
47
Types of Antibodies
48
T cells and Cell-Mediated Immunity
• T cell leaveing the thymus has a unique T-cell receptor (TCR)
• Unable to recognize antigen without help
– Must be presented to TCR by an MHC (major
histocompatibility complex) protein on surface of another cell
• Types of T cells
– Helper T (TH) cells
– Cytotoxic T (TC) cells
8/30/2013
17
49
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
T-cell receptor (TCR)
Tc cell
Figure 13.7
50
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
MHC-Icytokines
T-cell receptor (TCR)
Binding toMHC-I + antigen Dendritic
cell
Tc cell
viralantigen
Figure 13.7
51
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
MHC-Icytokines
Binding to
MHC-I + antigenDendritic
cell
viral
antigen
Cytotoxic
Tcell
virus-infected
cell
Death by
apoptosis
Activation and
clonal expansion
Tc cell
T-cell receptor (TCR)
Figure 13.7
8/30/2013
18
52
• TH cells recognize only those antigens presented by
specialized antigen-presenting cells (APCs) with MHC class II molecules on
their surface.
• TC cells recognize only those antigens presented by various cell types with MHC
class I molecules on their surface.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Cytotoxic
Tcell
virus-infected
cell
Death by
apoptosis
Activation and
clonal expansion
Apoptosis
Memory
T cell
cytokines
T-cell receptor (TCR)
Binding to
MHC-I + antigen Dendritic
cell
Tc cell
viral
antigen
MHC-I
Figure 13.7
53
13.2 Innate and Adaptive Immunity
• TC Cells
– TC cells provide immunity against virus-infected cells and cancer cells.
– TC cells have storage vacuoles.
• Perforins form pores in abnormal cell membrane
• Granzymes induce apoptosis
– Some T cells become memory T cells.
• May live many years
• Can quickly jump start immune response to previous antigen
54
vesicle
perforin
granzyme
Perforinformshole
in target cell.Granzymesenter through the
hole and causetarget cell to
undergo apoptosis.
Cytotoxic T cell
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Target cell
Figure 13.8a
8/30/2013
19
55
vesicle
perforin
granzyme
target cell
(virus-infected
or cancer cell)
Perforin
forms hole
in target cell.
Target cell
Granzymes
enter through the
hole and cause
target cell to
undergo apoptosis.
Cytotoxic T cell
cytotoxic T cell
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Figure 13.8a
56
a.
vesicle
perforin
granzyme
target cell(virus-infected
or cancer cell)
Perforinforms hole
in target cell.
Target cell
Granzymesenter through the
hole and causetarget cell to
undergo apoptosis.
cytotoxicT cell
target cell
SEM 1, 250 ××××
Cytotoxic T cell
cytotoxic T cell
b .
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
b: © Steve Gschmeissner/Photo Researchers, Inc.
Figure 13.8
57
Please note that due to differing operating systems, some animations will not appear until the presentation is viewed in Presentation Mode (Slide
Show view). You may see blank slides in the “Normal” or “Slide Sorter” views. All animations will appear after viewing in Presentation Mode and playing each animation. Most animations will require the latest version of the Flash Player,
which is available at http://get.adobe.com/flashplayer.
8/30/2013
20
58
Please note that due to differing operating systems, some animations will not appear until the presentation is viewed in Presentation Mode (Slide
Show view). You may see blank slides in the “Normal” or “Slide Sorter” views. All animations will appear after viewing in Presentation Mode and playing each animation. Most animations will require the latest version of the Flash Player,
which is available at http://get.adobe.com/flashplayer.
59
13.4 Active Versus Passive Immunity
• Immunity occurs when the body is protected
from various threats.
• Two types of adaptive immune responses
exist.
– Active immunity
• Individual alone produces an immune response against antigen
– Passive immunity
• Individual is given prepared antibodies either naturally or artificially by injection
60
Active Immunity
• Active Immunity
– Develops naturally after a person is infected
with an antigen
– Can be induced artificially – immunization
• Vaccine – substances that contain an antigen to which the immune system responds (traditionally)
– Genetically engineered microbes mass-produce antigens
– Depends on presence of memory B cells and
memory T cells
• Respond quickly to antigen if encountered again
8/30/2013
21
61Figure 13.9a
Suggested Immunization Schedule
Age (years)
4–6
11–12, 13–18
4–6
4–6, 11–12
2–18
2–18
11–12
Vaccine Age (months)
Birth, 1–2, 6– 18
2, 4, 6, 15– 18
2, 4, 6, 12– 15
Diphtheria, tetanus,Pertussis (DTP)
Hepatitis B
Tetanus only
Haemophilus
influenzae, type b
Polio (IPV)
Pneumococcal
Measles, mumps,rubella (MMR)
Varicella(chicken pox)
Hepatitis A(in selected areas)
Human papilloma-virus, types 6, 11, 16, 18
2, 4, 6–18
2, 4, 6, 12–15
12–15
12–18
12–18
–
a.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
(top): © The McGraw-Hill Companies, Inc. Jill Braaten, photographer
62
• Follow immune response using antibody titer
– 1st exposure – titer rises slowly
– 2nd exposure – titer rises rapidly and to a higher
level
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
0 30 60 90 120 150 180
high
low
secondary responseprimary response
Pla
sm
a A
nti
bo
dy
Co
ncen
tra
tio
n
first exposureto vaccine
Time (days)
second exposureto vaccine
Figure 13.9b
63Figure 13.9 b.
Suggested Immunization Schedule
Age (years)
4–6
11–12, 13–18
4–6
4–6, 11–12
2–18
2–18
11–12
Vaccine Age (months)
Birth, 1–2, 6– 18
2, 4, 6, 15– 18
2, 4, 6, 12– 15
Diphtheria, tetanus,
Pertussis (DTP)
Hepatitis B
Tetanus only
Haemophilus
influenzae, type b
Polio (IPV)
Pneumococcal
Measles, mumps,
rubella (MMR)
Varicella
(chicken pox)
Hepatitis A
(in selected areas)
Human papilloma-
virus, types 6, 11, 16, 18
2, 4, 6–18
2, 4, 6, 12–15
12–15
12–18
12–18
–
a.
high
18015060 12030 900
Time (days)
primary response secondary response
second exposure
to vaccine
Pla
sm
a A
nti
bo
dy
Co
nce
ntr
ati
on
low
first exposure
to vaccine
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
a (top): © The McGraw-Hill Companies, Inc. Jill Braaten, photographer
8/30/2013
22
64
Passive Immunity
• Passive Immunity
– Received from another person’s antibodies or immune cells
– Common natural process
• Cross placenta but last only a few months
• Found in breast milk which prolongs immunity
– Temporary because there are no memory cells
• Used to prevent illness in an exposed individual
65b: © Digital Vision/Getty RF; c: © Aaron Haupt/Photo Researchers, Inc.
a. Antibodies (IgG) cross the placenta.
b. Antibodies (IgG, IgA) aresecreted into breast milk.
c. Antibodies can be injected by aphysician.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Figure 13.10
66
Immune TherapiesCytokines and Immunity
• Cytokines are signaling molecules that regulate white blood cell formation or function.
– Medical uses of cytokines
• Stimulation of blood cell production in cancer patients whose treatment reduces normal function of bone marrow
• Treatment of cancer by stimulating the immune response
– Interferons used to directly inhibit cancer growth or inhibit viruses that may cause cancer
8/30/2013
23
67
Monoclonal Antibodies
• Monoclonal antibodies are group of plasma cells from the same B cell.
– All produce antibodies against the same antigen.
– Hybridomas are made in the lab by fusing antibody-producing cells with myeloma cells.
– Monoclonal antibodies have many uses.
• Diagnostic tests
– Ex: pregnancy tests
• Vehicles for drug delivery
• Identification of infections
68
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
myeloma cellsantigen
fusion into
hybridoma
b. Culture of surviving
hybridomas
c. Selection of antibody
producing clones
e. Purified monoclonal antibodies
a.
d. Clonal expansion of
antibody-producing cells
mouse spleen cells
Producing antibody
69
13.5 Adverse Effects of Immune Responses
• Sometimes the immune system responds
to harmless antigens in a manner that damages the body.
– allergic reaction
– incompatible blood type
– tissue rejection
8/30/2013
24
70
Allergies
• Allergies are hypersensitivities to substances such as pollen, food or animal hair.
– Such substances do not normally harm the body.
– The antigens that provoke such a response in these substances are called allergens.
71
Allergies• Immediate allergic response
– Can occur within seconds of contact with antigen
– IgE antibodies are attached to receptors on the plasma membrane of mast cells in the tissues and also to eosinophils and basophils in the blood
– Allergen attaches to IgE, causing mast cells to release histamine
– Histamine is responsible for allergy symptoms
– Examples – hay fever, asthma, food allergies
72
Allergies
• Anaphylactic shock is an immediate allergic response due to allergen entering the blood stream.
– Examples - bee stings, penicillin shots
– Response is characterized by a sudden, life-threatening drop in blood pressure due to the effects of histamine on capillaries.
– Epinephrine can counteract this reaction.
8/30/2013
25
73
Allergies
• Delayed allergic response– Initiated by memory T cells at the site of allergen
contact in the body
– Classic example is skin test for tuberculosis (TB)• Positive test result is skin becomes red and hardened
• Indicates previous exposure to TB
Figure 13.12
74
Blood-Type Reactions
• Several blood typing systems are currently in use.
• The ABO system is the most clinically important.
• Information about one’s ABO type should be easily accessible in case an accident requires the need for blood.
75
ABO system
– Presence or absence of type A and type B antigens on red blood cells determines a persons blood type
– Four types of blood – A, B, AB, and O
– Plasma contains antibodies to antigens NOT present on the red blood cells
– Two antibodies• Anti-A
• Anti-B
8/30/2013
26
76
ABO system
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
AA Anti-B
BB Anti-A
A, BAB None
NoneO Anti-A and anti-B
Antibody in
Plasma
Antigen on
Red Blood CellsBlood Type
77
ABO System
• Transfusions
– Must consider recipient’s antibodies and donor’s antigens to prevent agglutination (clumping) and transfusion reaction
– Type O is universal donor
• Neither anti-A nor anti-B antibodies
– Type AB is universal recipient
• Neither A nor B antigens
78
+
no binding
+
binding
500 ××××
type A blood
of donor
anti-B antibody of
type A recipient
type A blood
of donor
anti-A antibody of
type B recipient
a. No agglutination
b. Agglutination
500 ××××
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
(both): © J. C. Revy/Phototake
Figure 13.13
8/30/2013
27
79
Rh System
• Rh factor is another important antigen in blood matching.
– Rh-positive
• Rh antigen is present on red blood cells
• 85% of US population
– Rh-negative
• Rh antigen is absent on red blood cells
• 15% of US population
• Normally do not have antibodies to the Rh factor, but they may make them when exposed to the Rh factor
80
Rh System
• Significant in Pregnancy if an Rh-negative mother is pregnant with an Rh-positive baby
– If baby’s cells leak into mother’s bloodstream, she forms anti-Rh antibodies.
– In a subsequent Rh-positive pregnancy, those antibodies attack baby’s RBCs, causing hemolytic disease of newborn.
– This can be prevented by giving the Rh-negative mother anti-Rh immunoglobulins by injection.
• The injection must be given before the mother becomes sensitized to produce her own antibodies.
81
Rh-negativered
blood cell of mother
Rh-positive
red blood cellof fetus
Fetal Rh-positive red blood cells leak across placenta into
mother’s bloodstream.
blood of mother
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Figure 13.14a
8/30/2013
28
82
Mother forms anti-Rh antibodies that cross the placentaand attack fetal Rh-positive red blood cells.
blood of mother
anti-Rhantibody
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Figure 13.14b
83
Hemolytic Disease of the NewbornCopyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Rh-negativered
blood cell of mother
Rh-positive
red blood cell
of fetus
a. Fetal Rh-positive red blood cells leak across placenta into
mother’s bloodstream.
b. Mother forms anti-Rh antibodies that cross the placenta
and attack fetal Rh-positive red blood cells.
blood of mother blood of mother
anti-Rh
antibody
Figure 13.14
84
Tissue Rejection
• Organs such as kidney and heart would be relatively easy to transplant from one person to
another if it were not for the rejection process.
• MHC proteins serve as antigens when organs of a different MHC type are transplanted into a recipient.
• It is difficult to find exact MHC matches between recipient and donor.
• Rejection is diminished by immunosuppressivedrugs.
8/30/2013
29
85
Tissue Rejection
• Xenotransplantation
– Use of animal instead of human organs
– Genetic engineering to make pigs less antigenic by removing MHC antigens
– Ultimate goal - make pig organs as widely accepted as type O blood
86
13.6 Disorders of the Immune System
• Autoimmune Disease
– Cytotoxic T cells or antibodies attack a person’s own cells.
• Myasthenia gravis - muscle weakness due to attack of neuromuscular junctions
• Multiple sclerosis - neuromuscular disorder due to attack on nerve fibers’ myelin sheaths
• Systemic lupus erythematosus – kidney damage due to deposition of antigen-antibody complexes
• Rheumatoid arthritis – joints affected
87
13.6 Disorders of the Immune System
• Immunodeficiency disease
– Immune system is unable to protect the body from disease.
• Acquired immune deficiency syndrome (AIDS)
• Primary (or congenital) immunodeficiency
– Child inherits missing or impaired immune system
– Severe combined immunodeficiency syndrome (SCID)
» Both antibody- and cell-mediated immunity are lacking or inadequate